Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 29, 2026Nature CommunicationsOpen Access

Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlexandra MadsenNSNiklas SelfjordMMMarta Martínez-Lage

Discussion

Loading...

Member takes

Overview

Preclinical study reveals heterogeneous, organ-specific CRISPR-Cas9 off-target cuts and translocations in mouse models, highlighting the need for localized safety assessments.

Key Points

  • To establish workflows for mapping CRISPR-Cas9 off-target cleavage and structural variations at single-cell resolution and characterize tissue-specific editing outcomes in vivo.
  • Electroporated mouse embryos and embryonic stem cells to clonally analyze single-cell off-target mutations and chromosomal translocations.
  • Integrated single-cell editing data with chromatin accessibility, gene transcription, and DNA methylation measurements.
  • Profiled off-target spectra, DNA repair pathway utilization, indel patterns, and translocation frequencies across multiple tissues in Cas9-inducible mouse models.
  • Individual cells exhibited unique off-target mutations and translocation profiles that were undetected in standard bulk sequencing analyses.
  • Sequence-independent epigenetic features significantly influenced cleavage, with Cas9 showing preferential editing in regions marked by open chromatin and lower DNA methylation.
  • Cas9-inducible mice displayed distinct, organ-specific off-target profiles, DNA repair pathway choices, indel distributions, and markedly divergent translocation propensities.

Cite This Study

Madsen et al. (2026) studied this question.

synapsesocial.com/papers/6a9299088e5d7d1fc0c10c1ehttps://doi.org/10.1038/s41467-026-77144-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessing off-target effects in CRISPR/Cas9: challenges and strategies for precision DNA editing2026
  2. 2Human genetic diversity alters therapeutic gene editing off-target outcomes2021 · 5 citations
  3. 3Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing2024 · 85 citations
  4. 4Unveiling Off-Target Mutations in CRISPR Guide RNAs: Implications for Gene Region Specificity2024 · 4 citations
  5. 5Analytical dissection of CRISPR-Cas9-mediated gene editing fidelity: integrating next-generation bioanalytical platforms for precision immunotherapeutics and rare disease correction2026 · 1 citations